News & Events PhenoVista Biosciences and Inventia Life Science Enter Strategic Partnership to Accelerate Preclinical Research with 3D Cell Models.PhenoVista Biosciences and Yokogawa Life Innovations Partner to Provide Biopharma Researchers with Higher-quality Cell-based Assay OptionsPhenoVista Biosciences Receives $250K Phase 1 SBIR Grant for Microglia Models for Phenotypic Screening of Drugs in Alzheimer’s DiseaseIsoPlexis Names PhenoVista Biosciences a Certified Service ProviderPhenoVista Biosciences Announces $1.4M Phase 2 SBIR Grant for Phenotypic Drug Screening in Alzheimer’s DiseaseOlympus and PhenoVista Collaborate to Deliver an Innovative 3D Cell-Based Assay Service for Drug DiscoveryPhenoVista Biosciences and Champions Oncology Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays for Preclinical Drug Development
